Amgen (AMGN) |
United States |
$117.200B |
13.07 |
Gilead Sciences (GILD) |
United States |
$87.436B |
10.97 |
Biogen (BIIB) |
United States |
$65.478B |
12.69 |
Celgene (CELG) |
United States |
$63.576B |
11.78 |
Vertex Pharmaceuticals (VRTX) |
United States |
$48.081B |
64.41 |
Regeneron Pharmaceuticals (REGN) |
United States |
$46.330B |
21.52 |
Illumina (ILMN) |
United States |
$44.074B |
52.42 |
Alexion Pharmaceuticals (ALXN) |
United States |
$28.921B |
17.92 |
Incyte (INCY) |
United States |
$18.013B |
168.30 |
BioMarin Pharmaceutical (BMRN) |
United States |
$16.736B |
0.00 |
Seattle Genetics (SGEN) |
United States |
$11.477B |
0.00 |
Exact Sciences (EXAS) |
United States |
$10.883B |
0.00 |
Sarepta Therapeutics (SRPT) |
United States |
$9.252B |
0.00 |
Alnylam Pharmaceuticals (ALNY) |
United States |
$8.876B |
0.00 |
QIAGEN (QGEN) |
Netherlands |
$8.819B |
28.84 |
BeiGene (BGNE) |
Cayman Islands |
$7.856B |
0.00 |
Bio-Rad Laboratories (BIO.B) |
United States |
$7.748B |
49.54 |
Bluebird Bio (BLUE) |
United States |
$7.495B |
0.00 |
Bio-Techne Corp (TECH) |
United States |
$7.237B |
48.76 |
Moderna (MRNA) |
United States |
$7.053B |
0.00 |
Exelixis (EXEL) |
United States |
$6.655B |
15.57 |
Amarin (AMRN) |
Ireland |
$5.703B |
0.00 |
Galapagos (GLPG) |
Belgium |
$5.283B |
0.00 |
Alkermes (ALKS) |
Ireland |
$5.078B |
0.00 |
Array BioPharma (ARRY) |
United States |
$5.047B |
0.00 |
Guardant Health (GH) |
United States |
$4.379B |
0.00 |
ARGENX SE-ADR (ARGX) |
Netherlands |
$4.077B |
0.00 |
Horizon Pharma Public (HZNP) |
Ireland |
$3.884B |
15.98 |
Allogene Therapeutics (ALLO) |
United States |
$3.795B |
0.00 |
MorphoSys AG Unsponsored ADR (MOR) |
Germany |
$3.458B |
0.00 |
Emergent Biosolutions (EBS) |
United States |
$3.371B |
28.40 |
Blueprint Medicines (BPMC) |
United States |
$3.339B |
0.00 |
Intercept Pharmaceuticals (ICPT) |
United States |
$3.286B |
0.00 |
Ascendis Pharma (ASND) |
Denmark |
$3.087B |
0.00 |
Genomic Health (GHDX) |
United States |
$3.011B |
101.63 |
ACADIA Pharmaceuticals (ACAD) |
United States |
$2.908B |
0.00 |
Ultragenyx Pharmaceutical (RARE) |
United States |
$2.865B |
0.00 |
Global Blood Therapeutics (GBT) |
United States |
$2.722B |
0.00 |
Immunomedics (IMMU) |
United States |
$2.710B |
0.00 |
China Biologic Products (CBPO) |
China |
$2.701B |
19.23 |
Repligen (RGEN) |
United States |
$2.640B |
82.45 |
Ligand Pharmaceuticals (LGND) |
United States |
$2.569B |
18.45 |
Reata Pharmaceuticals (RETA) |
United States |
$2.566B |
0.00 |
Mirati Therapeutics (MRTX) |
United States |
$2.496B |
0.00 |
Akcea Therapeutics (AKCA) |
United States |
$2.472B |
0.00 |
Arena Pharmaceuticals (ARNA) |
United States |
$2.466B |
0.00 |
Halozyme Therapeutics (HALO) |
United States |
$2.463B |
54.97 |
Myriad Genetics (MYGN) |
United States |
$2.305B |
23.48 |
Amicus Therapeutics (FOLD) |
United States |
$2.162B |
0.00 |
Insmed (INSM) |
United States |
$2.087B |
0.00 |
Spark Therapeutics (ONCE) |
United States |
$1.992B |
0.00 |
Denali Therapeutics (DNLI) |
United States |
$1.991B |
0.00 |
Acceleron Pharma (XLRN) |
United States |
$1.961B |
0.00 |
Atara Biotherapeutics (ATRA) |
United States |
$1.846B |
0.00 |
Medicines (MDCO) |
United States |
$1.830B |
0.00 |
AnaptysBio (ANAB) |
United States |
$1.828B |
0.00 |
REGENXBIO (RGNX) |
United States |
$1.725B |
23.14 |
MyoKardia (MYOK) |
United States |
$1.719B |
0.00 |
NeoGenomics (NEO) |
United States |
$1.649B |
135.69 |
CRISPR Therapeutics AG (CRSP) |
Switzerland |
$1.636B |
0.00 |
Zai Lab Unsponsored ADR (ZLAB) |
China |
$1.630B |
0.00 |
Myovant Sciences (MYOV) |
United Kingdom |
$1.509B |
0.00 |
Innoviva (INVA) |
United States |
$1.497B |
4.13 |
Allakos (ALLK) |
United States |
$1.468B |
0.00 |
Aimmune Therapeutics (AIMT) |
United States |
$1.422B |
0.00 |
UniQure (QURE) |
Netherlands |
$1.396B |
0.00 |
Nabriva Therapeutics AG (NBRV) |
Ireland |
$1.380B |
0.00 |
ALECTOR INC (ALEC) |
United States |
$1.352B |
0.00 |
Momenta Pharmaceuticals (MNTA) |
United States |
$1.347B |
0.00 |
Clovis Oncology (CLVS) |
United States |
$1.344B |
0.00 |
Orchard Therapeutics Sponsored ADR (ORTX) |
United Kingdom |
$1.282B |
0.00 |
Lion Biotechnologies (IOVA) |
United States |
$1.272B |
0.00 |
Cambrex (CBM) |
United States |
$1.266B |
13.65 |
GOSSAMER BIO (GOSS) |
United States |
$1.221B |
0.00 |
Codexis (CDXS) |
United States |
$1.184B |
0.00 |
Autolus Therapeutics Sponsored ADR (AUTL) |
United Kingdom |
$1.172B |
0.00 |
WAVE Life Sciences (WVE) |
Singapore |
$1.108B |
0.00 |
Vanda Pharmaceuticals (VNDA) |
United States |
$1.107B |
44.92 |
Rubius Therapeutics (RUBY) |
United States |
$1.104B |
0.00 |
Deciphera Pharmaceuticals (DCPH) |
United States |
$1.092B |
0.00 |
Audentes Therapeutics (BOLD) |
United States |
$1.055B |
0.00 |
Puma Biotechnology (PBYI) |
United States |
$1.055B |
0.00 |
Rhythm Pharmaceuticals (RYTM) |
United States |
$1.034B |
0.00 |
Epizyme (EPZM) |
United States |
$1.020B |
0.00 |
Alder BioPharmaceuticals (ALDR) |
United States |
$0.978B |
0.00 |
Editas Medicine (EDIT) |
United States |
$0.960B |
0.00 |
Fate Therapeutics (FATE) |
United States |
$0.960B |
0.00 |
Kiniksa Pharmaceuticals (KNSA) |
Bermuda |
$0.958B |
0.00 |
Coherus BioSciences (CHRS) |
United States |
$0.948B |
0.00 |
Sangamo Therapeutics (SGMO) |
United States |
$0.897B |
0.00 |
Retrophin (RTRX) |
United States |
$0.889B |
0.00 |
Athenex (ATNX) |
United States |
$0.846B |
0.00 |
Vericel (VCEL) |
United States |
$0.845B |
0.00 |
CytomX Therapeutics (CTMX) |
United States |
$0.829B |
0.00 |
Novavax (NVAX) |
United States |
$0.815B |
0.00 |
G1 THERAPEUTICS (GTHX) |
United States |
$0.781B |
0.00 |
Apellis Pharmaceuticals (APLS) |
United States |
$0.778B |
0.00 |
InflaRx (IFRX) |
Germany |
$0.777B |
0.00 |
Arvinas (ARVN) |
United States |
$0.770B |
0.00 |
Intra-Cellular Therapies (ITCI) |
United States |
$0.765B |
0.00 |
Y-mAbs Therapeutics (YMAB) |
United States |
$0.761B |
0.00 |
Heska (HSKA) |
United States |
$0.743B |
60.84 |
Cellectis (CLLS) |
France |
$0.726B |
0.00 |
Principia Biopharma (PRNB) |
United States |
$0.723B |
0.00 |
ANI Pharmaceuticals (ANIP) |
United States |
$0.722B |
13.81 |
Dicerna Pharmaceuticals (DRNA) |
United States |
$0.718B |
0.00 |
Dynavax Technologies (DVAX) |
United States |
$0.698B |
0.00 |
Acorda Therapeutics (ACOR) |
United States |
$0.680B |
8.83 |
Cara Therapeutics (CARA) |
United States |
$0.670B |
0.00 |
Inotek Pharmaceuticals (RCKT) |
United States |
$0.663B |
0.00 |
Revance Therapeutics (RVNC) |
United States |
$0.654B |
0.00 |
RA PHARMCTL INC (RARX) |
United States |
$0.650B |
0.00 |
Viking Therapeutics (VKTX) |
United States |
$0.648B |
0.00 |
Twist Bioscience (TWST) |
United States |
$0.643B |
0.00 |
Intellia Therapeutics (NTLA) |
United States |
$0.607B |
0.00 |
AMAG Pharmaceuticals (AMAG) |
United States |
$0.577B |
0.00 |
Lexicon Pharmaceuticals (LXRX) |
United States |
$0.567B |
0.00 |
UROGEN PHARMA (URGN) |
Israel |
$0.565B |
0.00 |
Kura Oncology (KURA) |
United States |
$0.564B |
0.00 |
Eidos Therapeutics (EIDX) |
United States |
$0.563B |
0.00 |
Anika Therapeutics (ANIK) |
United States |
$0.562B |
23.25 |
Osiris Therapeutics (OSIR) |
United States |
$0.550B |
0.00 |
Synthorx (THOR) |
United States |
$0.546B |
0.00 |
ProQR Therapeutics (PRQR) |
Netherlands |
$0.542B |
0.00 |
Arcus Biosciences (RCUS) |
United States |
$0.529B |
0.00 |
Prothena (PRTA) |
Ireland |
$0.524B |
0.00 |
Zymeworks (ZYME) |
Canada |
$0.502B |
0.00 |
PDL BioPharma (PDLI) |
United States |
$0.486B |
7.93 |
UNITY Biotechnology (UBX) |
|
$0.476B |
0.00 |
Adaptimmune Therapeutics (ADAP) |
United Kingdom |
$0.466B |
0.00 |
Clementia Pharmaceuticals (CMTA) |
Canada |
$0.465B |
0.00 |
Scholar Rock Holding (SRRK) |
United States |
$0.462B |
0.00 |
ObsEva SA (OBSV) |
Switzerland |
$0.451B |
0.00 |
DBV Technologies (DBVT) |
France |
$0.450B |
0.00 |
Zealand Pharma (ZEAL) |
Denmark |
$0.450B |
4.96 |
Senesco Technologies (ELOX) |
United States |
$0.446B |
0.00 |
Replimune (REPL) |
United States |
$0.445B |
0.00 |
Agenus (AGEN) |
United States |
$0.433B |
0.00 |
Cytokineticsorporated (CYTK) |
United States |
$0.432B |
0.00 |
Nightstar Therapeutics Sponsored ADR (NITE) |
United Kingdom |
$0.424B |
0.00 |
Kezar Life Sciences (KZR) |
United States |
$0.420B |
0.00 |
Five Prime Therapeutics (FPRX) |
United States |
$0.411B |
0.00 |
OSMOTICA PHARM (OSMT) |
United States |
$0.406B |
0.00 |
BeyondSpring (BYSI) |
United States |
$0.404B |
0.00 |
Mesoblast (MESO) |
Australia |
$0.398B |
0.00 |
NuCana Sponsored ADR (NCNA) |
United Kingdom |
$0.373B |
0.00 |
ZIOPHARM Oncology Inc (ZIOP) |
United States |
$0.369B |
0.00 |
Kindred Biosciences (KIN) |
United States |
$0.367B |
0.00 |
Sinovac Biotech (SVA) |
China |
$0.367B |
0.00 |
AVROBIO (AVRO) |
United States |
$0.367B |
0.00 |
Stemline Therapeutics (STML) |
United States |
$0.365B |
0.00 |
Cellular Biomedicine (CBMG) |
United States |
$0.360B |
0.00 |
Inovio Pharmaceuticals (INO) |
United States |
$0.353B |
0.00 |
MeiraGTx Holdings (MGTX) |
United States |
$0.350B |
0.00 |
Gamida Cell (GMDA) |
Israel |
$0.339B |
0.00 |
Gritstone Oncology (GRTS) |
United States |
$0.337B |
0.00 |
Krystal Biotech (KRYS) |
United States |
$0.332B |
0.00 |
Achillion Pharmaceuticals (ACHN) |
United States |
$0.330B |
0.00 |
BioDelivery Sciences (BDSI) |
United States |
$0.328B |
0.00 |
MediciNova (MNOV) |
United States |
$0.322B |
0.00 |
Aduro Biotech (ADRO) |
United States |
$0.322B |
0.00 |
Abeona Therapeutics (ABEO) |
United States |
$0.318B |
0.00 |
Albireo Pharma (ALBO) |
United States |
$0.316B |
0.00 |
Urovant Sciences (UROV) |
United States |
$0.314B |
0.00 |
XBiotech (XBIT) |
United States |
$0.310B |
0.00 |
Constellation Pharmaceuticals (CNST) |
United States |
$0.308B |
0.00 |
Magenta Therapeutics (MGTA) |
United States |
$0.306B |
0.00 |
Evelo Biosciences (EVLO) |
United States |
$0.293B |
0.00 |
Enochian BioSciences (ENOB) |
United States |
$0.287B |
0.00 |
Sorrento Therapeutics (SRNE) |
United States |
$0.285B |
0.00 |
Biofrontera AG Sponsored ADR (BFRA) |
Germany |
$0.283B |
0.00 |
Solid Biosciences (SLDB) |
United States |
$0.283B |
0.00 |
Axsome Therapeutics (AXSM) |
United States |
$0.278B |
0.00 |
Geron (GERN) |
United States |
$0.274B |
0.00 |
Intec Pharma (NTEC) |
Israel |
$0.269B |
0.00 |
AC Immune SA (ACIU) |
Switzerland |
$0.261B |
0.00 |
Kadmon Holdings (KDMN) |
United States |
$0.259B |
0.00 |
Merus (MRUS) |
Netherlands |
$0.258B |
0.00 |
Eiger BioPharmaceuticals (EIGR) |
United States |
$0.254B |
0.00 |
Kodiak Sciences (KOD) |
United States |
$0.252B |
0.00 |
Seres Therapeutics (MCRB) |
United States |
$0.250B |
0.00 |
Liquidia Technologies (LQDA) |
United States |
$0.247B |
0.00 |
EYEPOINT PHARMACEUTICALS, INC (EYPT) |
United States |
$0.247B |
0.00 |
Kala Pharmaceuticals (KALA) |
United States |
$0.244B |
0.00 |
Verastem (VSTM) |
United States |
$0.244B |
0.00 |
Celcuity (CELC) |
United States |
$0.241B |
0.00 |
Adverum Biotechnologies (ADVM) |
United States |
$0.240B |
0.00 |
Synlogic (SYBX) |
United States |
$0.236B |
0.00 |
Kamada (KMDA) |
Israel |
$0.236B |
10.64 |
Paratek Pharmaceuticals (PRTK) |
United States |
$0.232B |
0.00 |
MannKind (MNKD) |
United States |
$0.231B |
0.00 |
Syros Pharmaceuticals (SYRS) |
United States |
$0.231B |
0.00 |
Peregrine Pharmaceuticals (CDMO) |
United States |
$0.229B |
0.00 |
Sutro Biopharma (STRO) |
United States |
$0.225B |
0.00 |
ResTORbio (TORC) |
United States |
$0.225B |
0.00 |
Strongbridge Biopharma (SBBP) |
United States |
$0.221B |
0.00 |
TOCAGEN INC (TOCA) |
United States |
$0.219B |
0.00 |
Athersys (ATHX) |
United States |
$0.217B |
0.00 |
Arbutus Biopharma (ABUS) |
Canada |
$0.215B |
0.00 |
LogicBio Therapeutics (LOGC) |
United States |
$0.209B |
0.00 |
ChromaDex (CDXC) |
United States |
$0.208B |
0.00 |
Cerecor (CERC) |
United States |
$0.207B |
0.00 |
Xenon Pharmaceuticals (XENE) |
Canada |
$0.204B |
0.00 |
Celyad SA (CYAD) |
Belgium |
$0.201B |
0.00 |
Aeglea BioTherapeutics (AGLE) |
United States |
$0.200B |
0.00 |
ADMA Biologics Inc (ADMA) |
United States |
$0.196B |
0.00 |
Aptinyx (APTX) |
United States |
$0.189B |
0.00 |
Compugen (CGEN) |
Israel |
$0.186B |
0.00 |
Axovant Sciences (AXGT) |
United Kingdom |
$0.185B |
0.00 |
Spero Therapeutics (SPRO) |
United States |
$0.182B |
0.00 |
Protagonist Therapeutics (PTGX) |
United States |
$0.178B |
0.00 |
Spring Bank Pharmaceuticals (SBPH) |
United States |
$0.174B |
0.00 |
Pieris Pharmaceuticals (PIRS) |
United States |
$0.166B |
0.00 |
Enzo Biochem (ENZ) |
United States |
$0.166B |
0.00 |
Menlo Therapeutics (MNLO) |
United States |
$0.164B |
0.00 |
Syndax Pharmaceuticals (SNDX) |
United States |
$0.159B |
0.00 |
VBI Vaccines (VBIV) |
United States |
$0.157B |
0.00 |
Mersana Therapeutics (MRSN) |
United States |
$0.156B |
0.00 |
Nymox Pharmaceutical (NYMX) |
Canada |
$0.155B |
0.00 |
Erytech Pharma SA Sponsored ADR (ERYP) |
France |
$0.151B |
0.00 |
Proteostasis Therapeutics (PTI) |
United States |
$0.149B |
0.00 |
OvaScience (MLND) |
United States |
$0.145B |
0.00 |
Allena Pharmaceuticals (ALNA) |
United States |
$0.143B |
0.00 |
Cohbar (CWBR) |
United States |
$0.137B |
0.00 |
BioXcel Therapeutics (BTAI) |
United States |
$0.136B |
0.00 |
Cue Biopharma (CUE) |
United States |
$0.134B |
0.00 |
Aerpio Pharmaceuticals (ARPO) |
United States |
$0.133B |
0.00 |
Unum Therapeutics (UMRX) |
United States |
$0.129B |
0.00 |
Organovo Holdings (ONVO) |
United States |
$0.128B |
0.00 |
Trevena (TRVN) |
United States |
$0.127B |
0.00 |
Oncobiologics (OTLK) |
United States |
$0.124B |
0.00 |
Fortress Biotech (FBIO) |
United States |
$0.124B |
0.00 |
Mustang Bio (MBIO) |
United States |
$0.122B |
0.00 |
Anavex Life Sciences (AVXL) |
United States |
$0.121B |
0.00 |
Corvus Pharmaceuticals (CRVS) |
United States |
$0.121B |
0.00 |
Checkpoint Therapeutics (CKPT) |
United States |
$0.121B |
0.00 |
Pluristem Therapeutics (PSTI) |
Israel |
$0.119B |
0.00 |
Eton Pharmaceuticals (ETON) |
United States |
$0.119B |
0.00 |
XOMA (XOMA) |
United States |
$0.118B |
0.00 |
Equillium (EQ) |
United States |
$0.113B |
0.00 |
Catalyst Biosciences (CBIO) |
United States |
$0.107B |
0.00 |
ASLAN Pharmaceuticals (ASLN) |
Singapore |
$0.102B |
0.00 |
ANIXA BIOSCIENCES INC (ANIX) |
United States |
$0.100B |
0.00 |
VTv Therapeutics (VTVT) |
United States |
$0.097B |
0.00 |
Chiasma (CHMA) |
United States |
$0.095B |
0.00 |
Neothetics (EVFM) |
United States |
$0.093B |
0.00 |
Signal Genetics (MGEN) |
United States |
$0.091B |
0.00 |
NantKwest (NK) |
United States |
$0.090B |
0.00 |
Brainstorm Cell Therapeutics (BCLI) |
United States |
$0.082B |
0.00 |
Cocrystal Pharma (COCP) |
United States |
$0.079B |
88.33 |
Merrimack Pharmaceuticals (MACK) |
United States |
$0.078B |
0.00 |
Tiziana Life Sciences Sponsored ADR (TLSA) |
United Kingdom |
$0.078B |
0.00 |
Verona Pharma American Depositary Share (VRNA) |
United Kingdom |
$0.078B |
0.00 |
AVEO Pharmaceuticals (AVEO) |
United States |
$0.077B |
0.00 |
Orgenesis (ORGS) |
United States |
$0.077B |
0.00 |
Alimera Sciences (ALIM) |
United States |
$0.076B |
0.00 |
Provention Bio (PRVB) |
United States |
$0.075B |
0.00 |
PHASEBIO PHARMA (PHAS) |
United States |
$0.074B |
0.00 |
Idera Pharmaceuticals (IDRA) |
United States |
$0.072B |
0.00 |
Aptose Biosciences (APTO) |
Canada |
$0.072B |
0.00 |
INMUNE BIO INC (INMB) |
United States |
$0.070B |
0.00 |
Cidara Therapeutics (CDTX) |
United States |
$0.070B |
0.00 |
Aridis Pharmaceuticals (ARDS) |
United States |
$0.069B |
0.00 |
Celldex Therapeutics (CLDX) |
United States |
$0.067B |
0.00 |
SESEN BIO, INC (SESN) |
United States |
$0.065B |
0.00 |
AEterna Zentaris (AEZS) |
United States |
$0.065B |
12.28 |
Sienna Biopharmaceuticals (SNNA) |
United States |
$0.062B |
0.00 |
OVID THERAPEUTC (OVID) |
United States |
$0.062B |
0.00 |
Prima BioMed (IMMP) |
Australia |
$0.060B |
0.00 |
Applied Genetic Technologies (AGTC) |
United States |
$0.059B |
0.00 |
Evogene (EVGN) |
Israel |
$0.058B |
0.00 |
INNOVATE BIOPHARMACEUTICALS, INC (INNT) |
United States |
$0.058B |
0.00 |
Ophthotech (OPHT) |
United States |
$0.058B |
0.00 |
Proteon Therapeutics (PRTO) |
United States |
$0.057B |
0.00 |
NewLink Genetics (NLNK) |
United States |
$0.057B |
0.00 |
Vaccinex (VCNX) |
United States |
$0.056B |
0.00 |
Eyenovia (EYEN) |
United States |
$0.056B |
0.00 |
Entera Bio (ENTX) |
Israel |
$0.054B |
0.00 |
VIVUS (VVUS) |
United States |
$0.054B |
0.00 |
ScPharmaceuticals (SCPH) |
United States |
$0.053B |
0.00 |
ARAVIVE, INC (ARAV) |
United States |
$0.053B |
4.67 |
Alcobra (ARCT) |
United States |
$0.053B |
0.00 |
Clearside Biomedical (CLSD) |
United States |
$0.051B |
0.00 |
Vascular Biogenics (VBLT) |
Israel |
$0.049B |
0.00 |
Bellerophon Therapeutics (BLPH) |
United States |
$0.048B |
0.00 |
VistaGen Therapeutics (VTGN) |
United States |
$0.045B |
0.00 |
Selecta Biosciences (SELB) |
United States |
$0.044B |
0.00 |
Bionano Genomics (BNGO) |
United States |
$0.042B |
0.00 |
Celsion (CLSN) |
United States |
$0.041B |
0.00 |
Caladrius Biosciences (CLBS) |
United States |
$0.041B |
0.00 |
OncoSec Medical (ONCS) |
United States |
$0.041B |
0.00 |
Moleculin Biotech (MBRX) |
United States |
$0.040B |
0.00 |
Motif Bio Plc (MTFB) |
United States |
$0.040B |
0.00 |
Arsanis (ASNS) |
United States |
$0.039B |
0.00 |
DiaMedica Therapeutics (DMAC) |
United States |
$0.038B |
0.00 |
AquaBounty Technologies (AQB) |
United States |
$0.038B |
0.00 |
Aptevo Therapeutics (APVO) |
United States |
$0.037B |
0.00 |
Leap Therapeutics (LPTX) |
United States |
$0.035B |
0.00 |
Oncolytics Biotech (ONCY) |
Canada |
$0.035B |
0.00 |
BiondVax Pharmaceuticals (BVXV) |
Israel |
$0.035B |
0.00 |
OncoMed Pharmaceuticals (OMED) |
United States |
$0.034B |
5.58 |
Curis (CRIS) |
United States |
$0.034B |
0.00 |
Sophiris Bio (SPHS) |
United States |
$0.033B |
0.00 |
Galena Biopharma (SLS) |
United States |
$0.031B |
0.00 |
AZURRX BIOPHARM (AZRX) |
United States |
$0.031B |
0.00 |
Catabasis Pharmaceuticals (CATB) |
United States |
$0.031B |
0.00 |
Adial Pharmaceuticals (ADIL) |
United States |
$0.030B |
0.00 |
TRACON Pharmaceuticals (TCON) |
United States |
$0.029B |
0.00 |
Aileron Therapeutics (ALRN) |
United States |
$0.028B |
0.00 |
IMMURON LTD (IMRN) |
Australia |
$0.028B |
0.00 |
Akari Therapeutics (AKTX) |
United Kingdom |
$0.028B |
0.00 |
Advaxis (ADXS) |
United States |
$0.028B |
0.00 |
Zosano Pharma (ZSAN) |
United States |
$0.026B |
0.00 |
Novelion Therapeutics (NVLN) |
Canada |
$0.025B |
0.00 |
GENPREX INC (GNPX) |
United States |
$0.024B |
0.00 |
Apricus Biosciences (SEEL) |
United States |
$0.023B |
0.00 |
GTx (GTXI) |
United States |
$0.023B |
0.00 |
Vical (VICL) |
United States |
$0.022B |
0.00 |
CytRx (CYTR) |
United States |
$0.020B |
0.00 |
Titan Pharmaceuticals (TTNP) |
United States |
$0.020B |
0.00 |
Fibrocell Science Inc (FCSC) |
United States |
$0.020B |
0.00 |
Sunesis Pharmaceuticals (SNSS) |
United States |
$0.020B |
0.00 |
Benitec Biopharma (BNTC) |
Australia |
$0.019B |
0.00 |
Gemphire Therapeutics (GEMP) |
United States |
$0.016B |
0.00 |
Novogen (KZIA) |
Australia |
$0.016B |
0.00 |
Cleveland BioLabs (CBLI) |
United States |
$0.016B |
0.00 |
ATyr Pharma (LIFE) |
United States |
$0.015B |
0.00 |
Soligenix (SNGX) |
United States |
$0.015B |
0.00 |
Therapix Biosciences (TRPX) |
Israel |
$0.014B |
7.25 |
Prana Biotechnology (PRAN) |
Australia |
$0.014B |
0.00 |
Genetic Technologies (GENE) |
Australia |
$0.014B |
0.00 |
Aytu Bioscience (AYTU) |
United States |
$0.013B |
0.00 |
TrovaGene (TROV) |
United States |
$0.013B |
0.00 |
Edge Therapeutics (EDGE) |
United States |
$0.013B |
0.00 |
MYOS RENS Technology (MYOS) |
United States |
$0.011B |
0.00 |
Alliqua BioMedical (ALQA) |
United States |
$0.011B |
0.00 |
Neuralstem (CUR) |
United States |
$0.010B |
0.00 |
Cyclacel Pharmaceuticals (CYCC) |
United States |
$0.010B |
0.00 |
Vital Therapies (VTL) |
United States |
$0.009B |
0.00 |
Dare Bioscience (DARE) |
United States |
$0.009B |
0.00 |
RestorGenex (DFFN) |
United States |
$0.008B |
0.00 |
Histogenics (HSGX) |
United States |
$0.008B |
0.00 |
Flex Pharma (FLKS) |
United States |
$0.007B |
0.00 |
Pulmatrix (PULM) |
United States |
$0.006B |
0.00 |
Stellar Biotechnologies (SBOT) |
United States |
$0.006B |
0.00 |
Cellect Biotechnology (APOP) |
Israel |
$0.006B |
0.00 |
ARCA Biopharma (ABIO) |
United States |
$0.005B |
0.00 |
ContraVir Pharmaceuticals Inc (CTRV) |
United States |
$0.004B |
0.00 |
Cytori Therapeutics Inc (CYTX) |
United States |
$0.004B |
0.00 |
Tenax Therapeutics (TENX) |
United States |
$0.002B |
0.00 |